There is great enthusiasm for the use of biologic therapies to treat a range of musculoskeletal injuries and pathologies. The ability for mesenchymal stem cells (MSCs) to differentiate into multiple cell types and release pro-regenerative growth factors holds great promise for musculoskeletal tissue engineering.